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Abstract
Gamma irradiated Trichomonas vaginalis was used to initiate a protective immune response in mice by intraperitoneal
inoculation using host mortality as the measure of virulence. Irradiated trichomonads of a virulent strain gave some immune
protection but no more so than the use of formalin-fixed, virulent trichomonads. A formalin-fixed virulent strain combined
with complete Freund's adjuvant (CFA) gave complete protection. Metabolically produced antigens do not appear to be
important inconferring protective immunity in these experiments. A common laboratory strain of T. vaginalis (ATCC 30001)
was used as an avirulent control. Itgave no protection against a virulent strain. Combining CFA with ATCC 30001 (avirulent)
gave partial protection indicating that a protective antigen is present, but needed an immune stimulant to be detected. IgG
analysis corresponded to the mortality results with the avirulent strain being the weakest responder and the strongest being the
formalin-fixed virulent strain with CFA. Western blot analysis indicated a band of about 31-kDa that was present using the
protocols that showed from partial to complete protection. This band was not present using the avirulent strain but appeared
with the addition of CFA. These results indicated that a 31-kDa protein is present in the avirulent strain but it requires an
immune stimulant tobe revealed. Whether this antigen confers protective immunity or not in the mouse intraperitoneal model
is an open question.
Introduction
Trichomonas vaginalis, a flagellated protozoan, produces a
fulminant vulvovaginitis in women. It is one of the most
common venereal disease agents and is transmitted by
males, who for the most part, may not have any symptoms
themselves. The general clinical aspects, chemotherapy, and
immunology have recently been reviewed by Krieger and
Alderete (1999). The drug metronidazole has been very
effective against this organism, but cases resistant to
treatment and drug resistant strains have been found.
Immunotherapy has been considered, but protective
immunity to this parasite appears tobe poor or non-existent
.However, evidence for both humoral and cell-mediated
immune responses have been found. This has given rise to
the possibility of a vaccine or at least for an
immunodiagnostic test that can be used for epidemiological
purposes.
Immunological studies on T. vaginalis have used the
mouse as the primary animal model. Three routes have
been used for antigen exposure to develop an immune
response and each has its positive and negative aspects:
Intraperitoneal (IP) and intramuscular (IM) injections and
vaginal inoculation are the routes used (Warren et al. 1960;
Honigberg, 1978; Abraham et al., 1996). IM models are
preferred to IP methods for antigen inoculation since IM
uses ulcer development as a measure of pathology and does
not cause host death as does IP. Vaginal models in mice,
although more closely related to the parasites normal site of
infection, are the most complex models. They require sterol
injections and/or manipulation of Lactobacillus flora to make
the vaginal vault receptive to maintaining T. vaginalis
populations (McGrory and Garber, 1992; Abraham et al.,
1996). Unfortunately, although more clinically realistic, the
vaginal model suffers from the same problem as the human
vagina. Direct exposure to antigen does not seem to
stimulate an apparent protective immunity. However, IM
injections combined with a vaginal model have been shown
to provide protection reducing parasite populations in
mouse vaginas (Abraham et al., 1996). It has been shown
that circulating antibodies may diffuse through the vaginal
mucosa and give some degree of protection, therefore
giving hope for developing an anti-trichomonad vaccine.
The more easily accomplished IP route has also been used
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for studying immune responses but has been most effective
in studying strain virulence (Honigberg, 1978). Death of the
host and time of death, usually in days, have been
measurements used to determine relative virulence of a
strain in the IP model.
The primary objective ofthis study was to use irradiated
T. vaginalis to stimulate a protective immune response using
the IP model. Protective antigens may be metabolically
produced rather then being part of the pathogen's cellular
structure. As a rule, reproduction is halted but the organisms
continue to metabolize. In some cases, reproduction has not
been affected, but the pathology usually produced has been
attenuated. Ithas been shown with a number of protozoan
parasites that irradiated cells can produce a more efficient
immune response than crude cellular extracts (Hostetler.,
1987). The IP route was considered tobe the best choice for
these experiments based on ease of manipulation of the
model and the fact that the environment of the peritoneal
cavity would serve as a nutritionally supportive locale for
irradiated trichomonad survival. Previous studies on the
survival of T. vaginalis with gamma radiation showed a
dosage whereby trichomonads would remain metabolically
active but unable to reproduce (Daly et al., 1991). Different
treatment protocols for preparation of antigen source were
used for comparison and as controls. IgG response was
measured for each of these treatments, and Western blot
analysis was used to detect protein(s) that might be
protective.
Materials and Methods
The experimental design include the following: (1)
selection of a virulent and avirulent strain of T. vaginalis
based on IP inoculation, (2) gamma irradiation of T.
vaginalis, (3) determination of the length of time irradiated
trichomonads would survive in vitro, (3) determination of
the number and quantity ofsensitizing antigen doses needed
to illicit a protective immune response, (4) IgG analysis to
correlate with the mortality or protection seen with
challenges to the respective inoculation protocols, and (5)
Western blot analysis to determine protein bands associated
with protective immunity.
A. Trichomonas vaginalis strains and Growth Medium. T.
vaginalis strain ATCC 30001 was used as the avirulent
agent, and two isolates from clinical cases of
trichomoniasis, designated Cj and C2,were used as the
virulent strains. Trichomonads were grown in TYM
medium (Diamond, 1957) with 10% heat inactivated
(56° C) Seitz-filtered human serum. Serum was obtained
from the clinical laboratories of the University of
Arkansas for Medical Sciences Hospital.
B. Experimental animals. Female BALB/c mice were
obtained from the National Center for Toxicological
Research (Jefferson, AR) or purchased from SASCO
Incorporated (Omaha, NE). Mice, 3 or 24 weeks ofage,
were used in some experiments to determine if age
affects the immune response.
C. Preparation of Inocula. T. vaginalis strains were grown to
a concentration of 104 /ml and passaged three times at
this population level to insure that cells were in the
logarithmic phase of growth. Cells were harvested from
100 ml of medium at 500xg in 50 ml centrifuge tubes.
The cells were resuspended and washed 3x in sterile
phosphate buffered-saline (PBS - pH 7.2). The final
pellet was suspended in buffer and adjusted to the final
cell concentrations to be used. T. vaginalis were
irradiated with gamma radiation from a Cesium 137
irradiator by the methods of Daly et al. (1991). Total cell
counts were made in a Neubauer hemocytometer, and
viable counts were with the semi-soft agar technique of
Ivy (1961) as modified by Matthews and Daly (1974).
D. Trypan Blue Dye Exclusion. Fifty (ilof cells to be tested
was removed from irradiated and control (nonirradiated
cells) culture tubes. Trypan blue dye was added to a
final concentration of 0.4%. After mixing, the two
suspensions were loaded into separate counting
chambers, and the number of total cells and the number
ofcells excluding the dye were determined. Final values
were from three counts.
E. Inoculation of Mice. Cell concentrations were adjusted
to contain a predetermined number in 200 ul for
intraperitoneal inoculation using tuberculin syringes
with 26g needles. Twenty gauge needles were used with
formalin-killed cells with complete Freund's adjuvant
(CFA). Immunizing inocula were prepared by
resuspending a pellet of cells in 0.5% formalin at 4°C for
1 hr. Irradiated cells were suspended in fresh, sterile
TYMmedium without serum.
F. Procurement of blood and anti-Trichomonad antibody
assay. Mice were anesthetized with methoxyfurane and
bled from the retroorbital plexis with heparinized
capillary tubes. The tubes were centrifuged, the plasma
removed, and the plasma stored at minus 20°C until
use. Dilutions of plasma were done two-fold starting
with 1/10 increasing to 1/256. These were placed in
slide wells. Fluorescein isothiocynate conjugated with
goat anti-mouse IgG (Cappel Laboratories, West
Chester, PA), diluted 1/20 in PBS, was then added to
the wells and incubated for 30 minutes at 37°C. The
sample wells were counterstained with Evans blue dye
and allowed to dry. Three controls were used - (a)
normal mouse serum, (b) immune mouse serum, (c) and
mouse serum with a known high titer to T. vaginalis.
Examination of the wells was with a Zeiss flourescence
microscope at X400 magnification. The antibody titer
was defined as the highest dilution of serum that
resulted in flourescence of the cells.
G. SDS-PAGE and Western Blot. Preparation oftrichomonad
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Trypan blue exclusion from irradiated and non-irradiated
Trichomonas vaginalis
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Fig. 1. Metabolic activity over time as demonstrated by trypan blue exclusion from irradiated ornon-irradiated Cj Trichomonas
vaginalis at 37°C. The 16 hour measurements are the final data points shown because there were no viable cells at 24 hours.
Cells were irradiated in TYMmedium with and without serum (one experiment).
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Fig. 2. Development ofserum IgG titers in 24 week-old mice to Trichomonas vaginalishy four sensitization protocols. Titers were
determined by indirect immunoflourescence using T. vaginalis Cj as the antigen source. Each group represents pooled plasma
samples from 5 mice.
Results
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produce a protective immunity through IP inoculation, a
radiation dose had to be found where the organisms could
survive, but not cause mortality in mice. The ability of T.
vaginalis to produce mortality after radiation was
determined by exposing 106 Cj trichomonads in TYM
medium to 100, 200, 400, and 800 Gy, respectively (Table
2). Mortalities of mice averaged 3.6, 5.8, and 5.8 days after
0, 100, and 200 Gy. No survival was seen inmice inoculated
with trichomonads exposed to 400 and 800 Gy. Since very
high dosages of radiation can cause cellular disruption and
disintegration of T. vaginalis, a trypan blue dye assessment
was made to determine if the cells would still remain
metabolically active and for how long after exposure to 400
Gy (400 Gy is not a sterilizing dose since 13% of the cells can
reproduce after 500 Gy - Daly et al., 1991). Figure 1 shows
the percent of cells excluding dye after given time periods at
37°C incubation. One set of non-irradiated cells (control)
was in TYMmedium without serum additive (to prevent
growth), another set was in similar medium, but had been
irradiated and a third set, also irradiated, had serum added
to duplicate conditions inside the peritoneal cavity. Allthree
sets remained metabolically active at 70 to 80% after 12
hours of incubation. The irradiated cells in TYMmedium
without serum then began to lose activity with only 1.8% of
cells excluding dye after 16 hours; irradiated cells with
added serum followed withonly 2.5% activity after 16 hours.
Neither of the irradiated sets was excreting dye at 24 hours.
As a result of these experiments 400 Gy was chosen as the
primary radiation dose for cells in TYM medium with
serum.
After one sensitizing dose of irradiated Cj T. vaginalis,
the mice (n = 5/set) were challenged with 10() cells of
nonirradiated Cj. This one dose did not confer protection
because those mice died earlier (3.4+0.5 days) than
unsensitized controls (4.0+0.0 days). Since one sensitization
did not produce protection, a series of three inoculations of
irradiated cells was administered, once a week, to increase
the possibility of obtaining protective immunity. These
preparations included formalinized C2 with the immune
stimulant complete Freunds adjuvant (CFA), formalinized
C2 without CFA, live avirulent ATCC 30001, formalinized
ATCC 30001 with CFA, and a sublethal dose (10 4) of C2(Table 3). Three sensitizing doses of irradiated cells did
produce some measure of protective immunity in the mice
that received irradiated cells as did the formalin-fixed C2
cells and the formalin-fixed avirulent cells with CFA. The
best protection was conferred with the use of virulent C2
formalinized cells withadded CFA.
IgG titers of adult mice showed that antibody response
using irradiated cells correlated with the mortality studies
(Fig. 2). CFA stimulated a faster response but the titer was
the same as all other titers, which did not differ after three
weeks. The avirulant ATCC 30001 control showed the least
stimulatory effect as would be expected from the mortality
studies, but the serum titer was also the same as the others
at the end of three weeks. Passive transfer of immunity was
tried with serum from these mice, but it was unsuccessful.
Three passages of sublethal dosages of 10^, 104,and 10 5 cells
of Cj were also used, but these showed noIgG titer after the
first week, 1:160 titer for only the 105 dose after weeks 2 and
3, and 1:80 for the lower dosages for week 3 only. The data
indicate that the amount of antigen administered is
important in the IgG response.
Fig. 3. Western blot analysis of serum from different mouse
treatment groups sensitized with Trichomonas vaginalis
antigen preparations. A protein extract from T. vaginalis C2
was separated according to molecular weight by SDS-Page.
The sensitization protocols used to obtain the sera for each
lane were (A) Normal mouse serum (control - no antigen
inoculated); (B) Formalin-fixed T. vaginalis ATCC 30001 +
CFA (partial protection); (C) Formalin-fixed T. vaginalis C2 +
CFA (complete protection); (D) Irradiated T. vaginalis C2(partial protection) ;(E) Formalin-fixed T. vaginalis C2 (partial
protection).
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Table 1. The effect of different intraperitoneal doses of Trichomonas vaginalis strains ATCC 30001 and Cj in five BALB/c mice
(N = 5/dose).
Inoculum (No.of trichomonads)* Inoculum Percent Survival Days to Death
PBS (control) PBS 100
ATCC 30001 1 x 106 C! 1 xl0a 100
ATCC 30001 2.5 x 106 C^ 1 xlO4 100
ATCC 30001 5 x 10(i C, 1 xl0r> 100
ATCC30001 1 x 107 Cj 1 xl0(i 0 5.8
C t 4 xl0(i 0 4.0
Cj 7 xl0(i 0 4.0
Cj 1 xlO7 0 4.0
Cj2 xlO7 0 2.0
*100% survival
Table 2. The mean time to death of female female Balb/c mice after intraperitoneal injection of Trichomonas vaginalis Cj that
were irradiated with different doses of ionizing radiation. Inoculum size was 10() for all groups, five mice in each group.
Radiation dose No. mice surviving/group Mean time to death
(Gray) (days ± SD)
0 0/5 3.6 ± 1.9
100 0/5 5.8 ± 1.4
200 0/5 5.6 ± 1.3
400 5/5
800 5/5
The Western blot analysis of serum from mouse
treatment groups with different levels of protection can be
seen in Figure 3. There were a large number of different
molecular weight proteins recognized by serum from all the
mouse treatment groups. There were, however, some
differences in the size of the proteins that were
demonstrated by this procedure. In the three treatment
groups sensitized with either virulent strain (Cj or C2) that
exhibited partial or complete protection (gamma irradiated,
formalin-killed, and formalin-killed plus CFA), there were
IgG antibodies toal vaginalis protein with an approximate
molecular weight of 31,000 (arrow, Fig. 3). This band did not
appear in the serum from animals that were sensitized with
the avirulent strain of ATCC 30001 (Hostetler, 1987).
However, when serum from mice that were sensitized with
the avirulent strain plus CFA was used as the antibody
source, this 31-kDa protein was also seen (arrow, Fig. 3).
Thus in all cases where protective immunity was
demonstrated, antibodies to this protein were seen.
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Table 3. The percent survival of BALB/C different aged mice after intraperitoneal challenge with live Cjor C2 virulent strains
of Trichomonas vaginalis after sensitizing the mice with different protocols. Ten mice were used for each group except where
noted. Three separate sensitizing inoculations for each group were done a week apart. Allsensitizations were accomplished
with 106 cells unless noted.
Sensitization Protocol Percent Surviving Challenge
Youngb Adultc
(3 weeks-old) (24 weeks-old)
ATCC 30001 0 0a
(live avirulent)
ATCC 30001 formalin-fixed 60
+ complete Freund's adjuvant
Sublethal (104 cells), Virulent 0 0
strain
Virulent strain, Formalin-fixed 20 60
Virulent strain, Gamma radiated (400 Gy) 20 40
Virulent strain, Formalin-fixed 100 100 d
+ complete Freund's adjuvant
a 5 mice used
b Cl (2 x 103 cells) used to challenge
c C2 (1 x 106 cells) used to challenge
d 20 mice used
Discussion peritoneal cavity to produce enough antigens
Radiation was first used to attenuate a parasitic
protozoan for vaccination purposes by Wallace and Sanders
in 1966 (Hostetler, 1987) using the murine parasite,
Trypanosoma lewisi. Since then there have been a number of
successful immunizations using this technique with
important parasitic protozoa such as Leishmania, Plasmodium,
Tbxoplasma, and Eimeria (Daly et al., 1991), including a study
in which protective immunity in human volunteers was
developed using irradiated sporozoites of Plasmodium
falciparum (Egan et al., 1993). In the present study, however,
the use of irradiated Trichomonas vaginalis in the mouse IP
model did not offer any advantage over other methods of
antigen preparation used in the study. It was originally
hypothesized that perhaps metabolic or other short-lived
antigens might produce a better immune response than
fixed or otherwise killed trichomonads. Failure to improve
on killed antigenic preparations is due either to the lack of
metabolically-produced protective immunogens or the
inability of the trichomonads to survive long enough in the
peritoneal cavity r antigens to stimulate a
protective response. In vitro, the cells were only able to
survive 16 hours as indicated by trypan blue exclusion, but
itis not known what the survival is in vivoin the peritoneum.
The use of a much greater inoculum size of irradiated
trichomonads might resolve this. However, the ability of the
avirulent, formalin-killed ATCC strain to confer some
protective immunity, when used with CFA, supports the
idea of a structural antigen more so than a metabolic one.
Also, the intraperitoneal route of antigen administration
used in this study is artificial since the natural site of
infection and where the most obvious pathology is
produced is the human vagina. Itwould be of interest to see
if radioattenuated T. vaginalis could stimulate an immune
response, protective or otherwise, in the mouse vagina (or in
human volunteers) by inoculation directly into the vagina or
by the IMroute.
The protective immunity, ifany, to Trichomonas vaginalis
inhuman females is poorly understood. IgG, IgA, and IgM
to T. vaginalis have all been found in both vaginal washings
and serum samples from patients or mouse models (Su,
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1982; Alderete, 1984; Cogne et al., 1985; Wos and Watt,
1986; Bhatt et al., 1992; Paintla et al., 2002) as has IgE (Su,
1982). In this study the only immunoglobulin response
measured was IgG in mouse serum. The IgG response
correlated well with the degree of protection obtained with
the different protocols and may indicate a protective role,
but IgA and IgM were not examined and these may be
involved in the protective immune responses seen. Cell-
mediated immunity (CMI) may also play a role. A mouse
footpad assay for delayed type hypersensitivity has shown
strong responses for formalin-fixed virulent strains, withand
without CFA, and irradiated virulent cells (Hostetler, 1987).
CMI responses to T vaginalis such as phagocytosis by
neutrophils have been found (Rein et al., 1980; Mason and
Forman, 1982), The cytokines TNF-a, IL2, LTB4, aINF,
and IL8 have been found to be stimulated by T vaginalis as
well (Shaio and Lin,1995 ;Shaio et al., 1995; Paintla et al.,
2002). Arole for complement has also been found (Alderete
and Kasmala, 1986; Caterina et al., 1999). Regardless, in
spite of evidence from the above cited studies, the immune
response in the vagina does not seem to confer obvious
protective immunity. Complicating possible protective
immunity is that the trichomonads can absorb host proteins
that could act as a protective barrier against antibodies (or
CMImechanisms) directed to surface receptors (Peterson
and Alderete, 1982). The variation, as observed in this study
with virulence, and more specifically with protein-epitopes
(Alderete et al., 1987; Dailey and Alderete, 1991; Fioriet al.,
1992) may also be a mechanism for immune avoidance.
The protective immune responses seen so far have not
been proven to be linked to any specific antigens conferring
protection although associations have been inferred. A
number of studies have focused on the most quantitatively
significant antigens (Addis et al., 1999) and those that might
be associated with virulence such as T vaginalis proteinases
(Alderete et al., 1991a, 1991b), cell membrane surface
proteins (Alderete, 1987; Alderete, 1999), and heat shock
antigens (Bozner, 1997; Davis-Haymer et al., 2000). Most of
these antigens have been high molecular weight proteins
(>100,000) but smaller immunogens have been found. Of
special interest is a 30-kDa proteinase detected by Arroyo
and Alderete (1995). Inhibition of this proteinase and
another proteinase of 65-kDa resulted in decreased levels of
T. vaginalis cytoadherence and totally abolished contact-
dependant cytotoxicity. Itmay be that the 31-kDa protein in
the present study and the 30-kDa proteinase are the same.
Live ATTC 30001 did not stimulate a visible antibody
response to this 31-kDA band. Although when stimulated
with CFA, the ATCC strain revealed this band showing that
the protein was present but inmuch smaller amounts. This
31-kDa protein may be coincidental with immune
protection or may be associated with a loss of virulence and
not related to protective immunity. Isolation of this protein
in sufficient quantity for immunization studies is needed to
determine ifitplays a any role inprotective immunity.
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